MD Buyline Reports: Carestream’s DR Systems Earn Highest Rating for Every Quarter of 2015

ROCHESTER, N.Y., Jan. 26 — Carestream Health earned the top rating in MD Buyline’s Market Intelligence Briefing™ for both portable and room-based digital radiography (DR) systems in every quarter of 2015. Carestream’s DRX-Revolution Mobile X-ray System and its DRX-Evolution, DRX-Evolution Plus and DRX-Ascend systems scored high marks from healthcare providers for performance, reliability, installation and service.

According to the report, “Carestream has been a dominant player in this market … Carestream steals the thunder from other vendors through ‘firsts,’ such as the first wireless panel in the U.S. market and the first collapsible column design made for a portable X-ray system.”

The report notes that Carestream’s third generation of DRX Plus detectors offer “a lighter-weight design, higher detective quantum efficiency (DQE), increased liquid resistance and improved battery life.”

Carestream was also praised in MD Buyline customer feedback sessions for its quality of workmanship, well-designed technology and outstanding customer service. According to the report, customers say “they can count on Carestream as an equal, working partner in their mission to deliver outstanding healthcare.”

“This report validates Carestream’s ongoing commitment to innovation and leadership in digital radiography. Our company’s fully featured, reliable DR systems are designed to meet the needs of hospitals, clinics, urgent care centers and other imaging services providers across the globe,” said Heidi McIntosh, Carestream’s Manager of Worldwide Marketing for Global X-ray Solutions.
MD Buyline’s reports are based on user satisfaction ratings in the following categories: system performance, system reliability, installation/implementation, applications training, service response time and service repair quality.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.